Target Product Profiles: Physician Insights on Key Attributes - Major Depressive Disorder, A therapy that can prevent recurrence of major depressive disorder in a greater percentage of patients than venlafaxine XR does at one year.

Table of Contents

• Introduction
  • Using Target Product Profi les in Your Market Strategy
  • Report Contents
  • Target Product Profi le Methodology
• Etiology and Pathophysiology
  • Overview
  • Etiology
  • Pathophysiology
    • The Monoamine Hypothesis
    • The Hippocampus Hypothesis
    • The Hypothalamic-Pituitary-Adrenal Axis Hypothesis
    • The Glutamate System
• Target Product Profi le Discussion-Major Depressive Disorder
  • Target Product Profi le Summary for Major Depressive Disorder-2011
  • Assessing Drug Development Opportunities
  • Physician Survey Results
    • Effi cacy
    • Safety and Tolerability
    • Delivery
    • Estimated Patient Share
  • Pricing Potential
  • Forecasted 2016 Pricing Environment
  • Competitors to Watch
  • Emerging Product Profi les